America's Biotech Leadership Depends on the States

By: Patrick Plues | RealClearHealth January 8, 2026

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

But other countries, including China, are sparing no expense in the bid to overtake us. Beijing has officially made biotechnology a national strategic priority and is pouring billions into state-backed research and manufacturing efforts.

All states should consider impactful biotech policies that grow and strengthen our domestic biotechnology industry. If states fail to utilize and replicate what are considered to be the best and most successful policies in biotech-focused economic development, the United States will soon lose its long-term leadership in developing medicines and medical technologies, which underpin our health, our economy, and our national security.

Thankfully, many governors and state legislatures around the country are already answering this call -- as our new study, The U.S. Bioscience Industry: A Powerful Engine for State Economies, demonstrates.


Keep Reading at https://www.realclearhealth.com/2026/01/08/americas_biotech_leadership_depends_on_the_states_1157584.html

June 1, 2026
Athens Bioscience, Inc. worked with an intern from the Biomanufacturing Program at ACCA developed by partnerships including local industry, county and State officials, educators, and Georgia Life Sciences. “We’ve got many large (biomanufacturing) corporations here in (Athens-Clarke) County,” ACCA Biotechnology Instructor Stan Harrison said. “They need skilled workers and they need them from all walks (of life).” As the program matures, students engage in internships at local industry sites to learn real-world applications for what they have learned through the Biomanufacturing pathway. Learning outcomes include not only the traditional biotechnology framework, but also automation and engineering fundamentals crucial in today’s biomanufacturing settings.
May 29, 2026
Biotechnology Workforce Alignment Act of 2026 pairs with a companion bill to assess and strengthen the federal biotech pipeline.
May 29, 2026
May 29, 2026 - Georgia Life Sciences is grateful to Governor Brian Kemp and the Georgia General Assembly for their continued investment in innovation, workforce development, and the future of Georgia’s life sciences ecosystem through the FY27 state budget. This funding, now in its 8th year, will support the continued growth of Georgia Life Sciences’ Biotech Teacher Training Initiative (BTTI) and strengthen our mission to build a world-class life sciences workforce pipeline across the state. By equipping educators with hands-on biotechnology and medtech training, industry-aligned curriculum (integrating medtech/AI/robotics), and real-world learning experiences, we are helping prepare students for high-demand careers in Georgia’s rapidly growing life sciences sector. Georgia continues to demonstrate national leadership by investing in the infrastructure, talent, and partnerships needed to drive scientific innovation, economic growth, and improved health outcomes. We appreciate the support of Governor Kemp and members of the General Assembly who recognize the critical role the life sciences industry plays in Georgia’s economy and future competitiveness.
MORE POSTS